Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RAPT Therapeutics (RAPT) Amortizatization of Intangibles: 2020-2024

Historic Amortizatization of Intangibles for Therapeutics (RAPT) over the last 5 years, with Dec 2024 value amounting to $530,000.

  • Therapeutics' Amortizatization of Intangibles fell 56.70% to $530,000 in Q4 2024 from the same period last year, while for Dec 2024 it was $2.8 million, marking a year-over-year decrease of 50.96%. This contributed to the annual value of $2.8 million for FY2024, which is 50.96% down from last year.
  • Therapeutics' Amortizatization of Intangibles amounted to $530,000 in Q4 2024, which was down 3.99% from $552,000 recorded in Q3 2024.
  • In the past 5 years, Therapeutics' Amortizatization of Intangibles ranged from a high of $1.6 million in Q3 2023 and a low of -$2.1 million during Q4 2021.
  • In the last 3 years, Therapeutics' Amortizatization of Intangibles had a median value of $701,500 in 2022 and averaged $737,083.
  • Data for Therapeutics' Amortizatization of Intangibles shows a peak YoY increase of 5,350.00% (in 2021) and a maximum YoY decrease of 1,021.40% (in 2021) over the last 5 years.
  • Over the past 5 years, Therapeutics' Amortizatization of Intangibles (Quarterly) stood at $229,000 in 2020, then tumbled by 1,021.40% to -$2.1 million in 2021, then skyrocketed by 131.04% to $655,000 in 2022, then skyrocketed by 86.87% to $1.2 million in 2023, then plummeted by 56.70% to $530,000 in 2024.
  • Its last three reported values are $530,000 in Q4 2024, $552,000 for Q3 2024, and $748,000 during Q2 2024.